Skip to content

A retrospective study of clinical characteristics of type 2 diabetes in the elderly with sarcopenia

A retrospective study of clinical characteristics of type 2 diabetes in the elderly with sarcopenia - A retrospective study of clinical characteristics of type 2 diabetes in the elderly with sarcopenia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000038446
Enrollment
41
Registered
2019-10-30
Start date
2019-09-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

None listed

Sponsors

Nihon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes mellitus aged 65 years and above, who admitted to Nihon University School Hospital for diabetes education.

Exclusion criteria

Exclusion criteria: Patients in whom grip strengths were not assessed.

Design outcomes

Primary

MeasureTime frame
HbA1c

Secondary

MeasureTime frame
Dominant hand grip strength, mini-mental state examination (MMSE) score, age, sex, body mass index (BMI), waist circumference, and blood pressure. The duration of diabetes mellitus, a family history of diabetes mellitus, current smoking, habitual alcohol use, uses of insulin and statins, a history of hypertension and dyslipidemia, and a history of cardiovascular, cerebrovascular, and peripheral artery diseases. Diabetic peripheral neuropathy, coefficient of variation of the R-R interval (CVR-R), diabetic retinopathy, diabetic nephropathy, maximum intima-media thickness, cardio-ankle vascular indexes, ankle-brachial indexes. Glycated albumin, total lymphocyte count, hemoglobin, albumin, aspartate aminotransferase, alanine aminotransferase, serum creatinine, eGFR, sodium, potassium, chloride, corrected calcium, phosphorus, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglyceride, uric acid.

Countries

Japan

Contacts

Public ContactSho Tanaka

Nihon University Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine

tanaka.sho@nihon-u.ac.jp81-3-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026